By reducing body weight, tirzepatide can help alleviate symptoms of obstructive sleep apnea, reduce joint pain from mechanical stress, and improve cardiovascular markers associated with heart disease
A 2024 post-hoc analysis (Aronne et al., Obesity) compared patients who switched from semaglutide to tirzepatide in real-world settings
Retatrutide, on the other hand, is still in clinical trials, so theres no official price yet
Resources: GLP-1 Agonists Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes Safety of Semaglutide Once-Weekly Semaglutide in Adults with Overweight or Obesity Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity Medication-Induced Gastroparesis: A Case Report Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASSCVOT design and baseline characteristics Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial Tirzepatide prevents neurodegeneration through multiple molecular pathways TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Biology of Incretins: GLP-1 and GIP GIP and GLP1, the two incretin hormones: Similarities and differences GLP-1, GIP and glucagon receptor poly-agonists: A new era in obesity pharmacotherapy
At Boulder Holistic Functional Medicine in Boulder, Colorado, we take a comprehensive approach to PCOS care, combining the latest research-backed treatments with personalized lifestyle recommendations to help you achieve optimal hormonal health
The program price covers your personalized medication prepared by a licensed US pharmacy and delivered monthly, in-person visits with Oliver Morris, DO, baseline and follow-up labs at scheduled checkpoints, titration, side-effect management, and nutrition guidance
